HR Execs on the Move

Apollo Endosurgery

www.apolloendo.com

 
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo`s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo`s products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the X-Tack™ Endoscopic HeliX Tacking System, and the ORBERA® Intragastric Balloon.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.apolloendo.com
  • 1120 South Capital of Texas Highway Building 1, Suite 300
    Austin, TX USA 78746
  • Phone: 512.279.5100

Executives

Name Title Contact Details
Steve Bosrock
 Vice President of Marketing Profile
Kirk Ellis
 Vice President of United States Sales Profile

Similar Companies

Bioness

Bioness offers award-winning medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and

Tibro Medical

Tibro Medical is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FONAR Corporation

Fonar Corporation (Fonar) operates in two business segments: medical equipment segment, and physician management and diagnostic services segment. Fonar is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance

Philips Respironics, Inc.

Philips Respironics, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

EndoStim

EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs). EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease -- namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.